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HR-pQCT has been used to define cortical and trabecular bone changes at
different anatomical sites involved in the disease processes of rheumatoid
arthritis (RA), which include the distal radius, the proximal interphalangeal
joints and the metacarpophalangeal joints. Three HR-pQCT studies have
shown that RA is associated with a significant reduction in cortical and
trabecular volumetric bone mineral density (vBMD), microstructure and
biomechanical indices at the distal radius compared to controls. Inflamma-
tion-associated increased bone resorptive activity produces greater deficits
in cortical than trabecular bone, and the changes were more pronounced
than those revealed by areal BMD (aBMD), independent of body weight,
hormonal level and aBMD. Changes in density and microstructure in RA
patients correlated with disease activity, disease severity and serum levels
of proinflammatory cytokines.
HR-pQCT is also useful for defining the anatomical sites prone to develop bone
erosions aswell as to quantify the size of such erosions. Boneerosions of>2mm
width in cortical break have been identified as highly specific for inflammatory
joint diseases. The pathogenesis of these lesions is unclear, but mechanical
forcesmight beconsidered as the potential triggers. Furthermore,HR-pQCThas
been helpful in validating the capability of other imaging techniques, such as
MRI and ultrasonography, in detecting bone erosions. HR-pQCT has been shown
to be particularly useful in monitoring the dynamics of individual bone erosions
and their responsiveness to treatment. Repair processes of existing bone
erosions have been studied in a longitudinal manner and were identified in
patients with RA treated with cytokine-blocking agents such as the TNF
inhibitors as well as the IL-6-receptor blocker tocilizumab.
Aside from bone erosions, HR-pQCT is also useful for visualizing early
nonerosive cortical bone changes in patients with RA. Areas of the
periarticular bone where the cortical lining is thin and porous (cortical
fenestration) have been defined by HR-pQCT. In patients with RA-specific
autoantibodies against citrullinated proteins, such lesions have also been
identified before they develop inflammatory disease, suggesting that bone is
altered by autoimmunity in patients with RA before inflammation emerges,
and creates new concepts in understanding the pathogenesis of RA.
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MOLECULAR IMAGING TECHNOLOGIES FOR OSTEOARTHRITIS/
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Department of Pathology, University of Rochester, USAArthritis, including rheumatoid arthritis and osteoarthritis, is a common
disease affecting millions of people worldwide. Murine models of arthritis are
an important tool for both the preclinical study of arthritis pathogenesis and
the testing the efficacy of anti-arthritis drugs, which have significantly
advanced our understanding of arthritis. However, they are limited by a lack
of longitudinal translational outcome measures of disease progression or
interventional therapy. This issue presents 3 problems for prototypical
preclinical investigations of drug effects on inflammation and tissue damages:
1) most cross-sectional studies in mice with “established arthritis” do not
include an objective assessment of disease severity prior to treatment, and
neither rates of change nor healing responses can be assessed; 2) the
commonly used end points (i.e., histology and ex vivo molecular analyses)
require the death of themice, thusmarkedly increasing the number of animals
needed to assess efficacy at multiple time points; 3) although the incidence
and severity of arthritis vary among genetically identical littermates, there
are no established scoring criteria to stratify different groups ofmice based on
disease activity in an intervention study. To overcome these problems, our
group recently developed several imaging techniques based on their clinically
used protocols. These techniques include contrast-enhanced magnetic
resonance imaging, near-infrared lymphatic imaging, and Power Doppler
ultrasound, which allow us to assess disease activity and progression in vivo in
arthritic mice longitudinally. We used these in vivo imaging techniques in TNF
transgenic mice, a mouse model of rheumatoid arthritis, and a Meniscal
Ligamentous Injury-induced mouse model of osteoarthritis to study the
association between synovial lymphatic draining function and the develop-
ment and progression of joint lesions in these mice, as well as the in responses
to a lymphatic based therapy. In this presentation, Iwill present ourwork using
these imaging techniques. I will also introduce recently developed near-
infrared dye based molecular imaging in preclinical arthritis study. Thus,
molecular imaging technologies will greatly enhance the utility of murine
models of arthritis in biological research.
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